Endocyte inc (ECYT)
CashFlow / TTM
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net loss

-41,338

-51,998

-52,178

-55,064

-57,564

-43,005

-45,223

-43,887

-42,616

-43,911

-40,552

-41,269

-39,556

-35,229

-2,268

5,459

10,637

13,271

-17,312

-18,032

-15,978

-14,177

-11,383

-17,291

-27,197

-38,027

-43,113

-40,531

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

819

855

886

922

941

944

940

919

900

888

880

886

893

889

879

857

815

773

731

674

603

525

434

358

306

276

263

262

0

0

0

Stock-based compensation

5,940

5,010

4,393

4,170

4,113

4,733

8,370

9,322

9,589

9,935

7,324

6,920

6,989

6,854

7,457

8,025

7,910

8,093

7,161

6,059

5,180

4,186

3,388

3,022

2,863

2,688

2,556

1,960

0

0

0

Loss (gain) on disposal of property and equipment

13

56

-102

-106

0

0

0

-

-

-

-

-10

17

7

7

6

-3

-2

-4

-1

0

0

0

-

-

-

-

-

-

-

-

Amortization of debt discount

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of bond premium

-

-

-

-161

64

173

242

395

614

864

1,167

1,310

1,332

1,512

1,612

1,615

1,661

1,522

1,309

1,246

1,292

1,324

1,225

961

717

407

323

343

0

0

0

Non cash interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3

73

118

248

395

646

0

0

0

Change in operating assets and liabilities:
Receivables

-68

25

-156

-1

-178

-124

-205

-191

-200

-373

-146

-856

-4,094

-5,453

-6,082

-5,490

6,081

4,930

3,941

2,508

-10,124

-1,624

-149

1,409

0

0

0

-

-

-

-

Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Accounts and accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Prepaid expenses and other assets

8,253

2,169

-181

-915

-743

-432

24

517

138

-350

-346

96

79

-439

-3,503

-2,711

-3,122

-3,204

-746

-2,016

-263

-97

359

1,287

463

786

1,565

-932

0

0

0

Accounts payable

692

-420

-158

-1,025

-1,517

-215

290

-252

464

-450

-810

-60

-123

-1,697

-1,940

-3,700

-3,993

-1,409

-320

-386

623

534

-1,163

524

-848

-958

61

943

0

0

0

Accrued wages, benefits and other liabilities

3,010

499

-354

-13

528

798

248

-771

-1,477

-791

-827

-777

-3,785

-7,911

-4,401

-2,923

478

3,822

818

1,337

2,421

5,161

4,426

3,483

1,251

-950

46

838

0

0

0

Deferred revenue

-60

-56

-53

-50

-50

-50

-50

-50

-50

-50

-50

-50

-50

-50

-46,588

-59,746

-62,228

-75,214

-41,661

-41,488

-48,467

-43,249

86,759

99,757

0

0

0

-

-

-

-

Net cash used in operating activities

-40,533

-32,626

-30,880

-33,658

-35,955

-35,921

-34,997

-34,650

-32,459

-32,728

-32,314

-32,218

-30,275

-29,735

-35,660

-42,205

-47,672

-50,862

-52,462

-51,080

-43,929

-39,141

84,114

89,191

81,248

76,367

-40,556

-34,584

0

0

0

Investing activities
Purchases of property and equipment

78

53

58

82

95

291

707

713

750

713

332

341

363

658

880

1,501

1,574

1,293

1,416

827

883

1,650

1,763

1,862

1,662

878

394

234

0

0

0

Proceeds from disposal of property and equipment

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of investments

363,412

197,276

119,450

106,724

76,349

71,480

113,057

139,932

149,435

140,488

95,021

86,281

84,011

71,976

167,411

149,370

133,009

149,687

86,213

125,026

130,990

171,758

276,342

265,203

286,705

266,558

168,419

236,930

0

0

0

Proceeds from sale and maturities of investments

143,800

109,800

130,430

134,930

132,330

145,730

142,000

190,765

186,080

172,212

138,216

88,114

96,030

97,579

96,924

82,302

76,688

66,189

136,106

195,146

189,704

209,650

141,338

163,671

190,293

175,422

233,268

169,853

0

0

0

Proceeds from issuance of subordinated convertible notes, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,590

0

0

0

Net cash provided by (used in) investing activities

-220,033

-100,195

-1,787

15,367

43,562

73,958

28,235

50,118

35,893

31,011

42,863

1,490

11,665

24,954

-71,357

-68,560

-57,895

-84,790

48,476

69,292

57,830

36,240

-136,766

-103,395

-98,075

-92,014

64,454

-67,311

0

0

0

Stock repurchase

104

104

106

94

100

100

148

164

158

158

108

57

57

61

61

3

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of common stock in connection with equity offering

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the exercise of stock options

10,816

7,466

3,374

1,087

241

261

183

261

168

155

174

379

838

1,043

1,297

1,290

825

922

815

644

635

485

398

391

460

762

693

595

0

0

0

Proceeds from stock purchases under employee stock purchase plan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

78,167

0

0

0

Net cash provided by financing activities

280,656

92,937

88,838

5,621

4,839

303

266

328

283

270

370

627

1,059

1,260

103,440

103,491

102,917

103,018

815

644

635

485

-13,145

-13,152

-13,083

52,582

64,720

146,381

0

0

0

Effect of exchange rate

-

-

-

-

-

-

-

-

-

-

-

-1

-5

-11

-38

-38

-23

-14

-6

-6

-19

-21

-0

0

0

0

0

-

-

-

-

Net increase (decrease) in cash and cash equivalents

-

-

56,170

-

-

-

-6,496

15,796

3,717

-1,447

10,918

-30,101

-17,557

-3,532

-3,616

-7,313

-2,673

-32,647

-3,177

18,850

14,517

-2,437

-65,799

-27,355

-29,912

36,930

88,614

44,479

0

0

0